
Tusamitamab
CAS No. 2349294-95-5
Tusamitamab( —— )
Catalog No. M37098 CAS No. 2349294-95-5
Tusamitamab is an IgG1 monoclonal antibody targeting CEACAM5 and is the naked antibody for Tusamitamab ravtansine. =
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 301 | Get Quote |
![]() ![]() |
5MG | 563 | Get Quote |
![]() ![]() |
10MG | 903 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameTusamitamab
-
NoteResearch use only, not for human use.
-
Brief DescriptionTusamitamab is an IgG1 monoclonal antibody targeting CEACAM5 and is the naked antibody for Tusamitamab ravtansine. =
-
DescriptionTusamitamab is an IgG1 monoclonal antibody that targets CEACAM5. Tusamitamab can be used to synthesize Tusamitamab ravtansine (SAR408701), which is a first-in-class humanized antibody-drug conjugate (ADC) that combines Tusamitamab and DM4 (a potent maytansine derivative).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2349294-95-5
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Clemence Pouzin, et al. Covariate analysis of tusamitamab ravtansine, a DM4 anti-CEACAM5 antibody-drug conjugate, based on first-in-human study. CPT Pharmacometrics Syst Pharmacol. 2022 Mar;11(3):384-394.?
molnova catalog



related products
-
Nifursol
Nifursol is a livestock feed additive and antiobiotic used to prevent the growth of histomonas.
-
Anigorufone
Anigorufone (2-hydroxy-9-phenyl-1H-phenalen-1-one) is a phenylphenylcinnamone compound isolated from the seeds of Ensete superbum (Roxb.) Cheesman. and Schiekia timida.
-
Anagyrine
Anagyrine, is the responsible teratogen from teratogenic lupins, can produce congenital deformities in calves typical of crooked calf disease.